Iteos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, last...
Up to date
Appointments
Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing potentially best-in-class,...
Pieris Pharmaceuticals, Inc. today announced that Maya R. Said, Sc.D., has joined the Company’s Board of...
Healx, a Cambridge, UK, technology company developing treatments for rare diseases, today announces the...
Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical Company active in the discovery and...
Zelluna Immunotherapy, a biotechnology company specializing in T-cell receptor (TCR) immunotherapies,...
Share
